This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert A. Shaw, MD; Michael E. Whitcomb, MD; Steven A. Schonfeld, MD

Arch Intern Med. 1981;141(6):741-742.

Abstract
Two patients with adult respiratory distress syndrome (ARDS) caused by Legionnaires' disease were treated with erythromycin lactobionate, and they survived. Sequential pulmonary function studies and chest roentgenograms were obtained in both patients. Despite previous suggestions that severe fibrosis might complicate the recovery of patients with this disease, both patients had normal lung volumes and only minimal reduction in single-breath carbon monoxide diffusing capacity ten weeks after the onset of the disease. Thus, pulmonary function after ARDS caused by Legionnaires' disease seems to be only minimally disturbed.

(Arch Intern Med 1981;741-742)

Author Affiliations
From the Pulmonary Disease Division, Ohio State University College of Medicine, Columbus.

Footnotes
Accepted for publication April 14, 1980.

Reprint requests to Pulmonary Disease Division, N325 Means Hall, Ohio State University Hospitals, 466 W 10th Ave, Columbus, OH 43210 (Dr Shaw).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
Herridge et al.
NEJM 2003;348:683-693.
ABSTRACT | FULL TEXT